Cepheid Updated Cepheid SARS-CoV-2, Flu, RSV Test Nabs FDA EUA The new version of the multiplex test adds a third gene target for SARS-CoV-2 to detect future viral mutations. Cepheid Gets $28M From BARDA for SARS-CoV-2 Tests The funding is for the firm's SARS-CoV-2, pan-coronavirus, and multiplex SARS-CoV-2, influenza, and respiratory syncytial virus tests, according to BARDA. Cepheid Nabs CE Mark for PCR-Based HIV-1 Tests Both tests run on any of the firm's GeneXpert systems and add second targets for HIV detection and early identification. Pandemic Pushes Handheld qPCR Devices Closer to Commercialization Premium Miniaturized sample-to-answer devices in development hint at an evolving molecular diagnostics landscape but launch timelines for these platforms remain unclear. Demand for Cepheid SARS-CoV-2 Point-of-Care Tests Expected to Continue Through 2022 Premium The Danaher subsidiary's core revenues grew more than 90 percent in the first quarter of 2021 and it expects to ship 45 million SARS-CoV-2 tests for the year. Apr 22, 2021 Danaher Q1 Revenues Up 58 Percent Apr 13, 2021 Danaher Expects Q1 2021 Revenue Growth Above Previous Guidance Mar 31, 2021 FDA Posts Info on Impact of SARS-CoV-2 Mutations on Test Effectiveness Feb 18, 2021 WHO Finds High Diagnostic Accuracy in Three Classes of MDx Technologies for TB Testing, Resistance Jan 28, 2021 Danaher Q4 Revenues up 39 Percent Dec 29, 2020 Cepheid Gets FDA Emergency Use Authorization for US Department of Defense Coronavirus Test Dec 1, 2020 Cepheid, Roche Coronavirus Tests Get FDA Emergency Use Authorization Nov 24, 2020 Cepheid Receives CE Mark for SARS-CoV-2, Flu A/B, RSV Combination Test Nov 17, 2020 Cepheid Developing New Target for BCR-ABL Test for Leukemia Patients Premium Oct 22, 2020 Danaher Q3 Revenues Up 35 Percent Oct 9, 2020 India Banks on Decentralized Molecular COVID-19 Testing Premium Sep 25, 2020 Cepheid Multiplex SARS-CoV-2, Flu, RSV Test Nabs FDA Emergency Use Authorization Sep 8, 2020 As Flu Season Nears, Dx Companies Shift Attention to Multiplex Tests for SARS-CoV-2, Influenza Premium Jul 31, 2020 SARS-CoV-2 E Gene SNP Raises Concerns About Test Accuracy, Transparency Premium Jul 23, 2020 Danaher Q2 Revenues Spike 19 Percent Jul 21, 2020 AdvaMed Partners With Dx Companies to Create National COVID-19 Supply Registry Jul 17, 2020 Cepheid Debuts 10-Color Molecular Detection Technology With New Tuberculosis Test Premium May 14, 2020 New Study Finds Abbott's ID Now SARS-CoV-2 Test Misses Sensitivity Mark May 7, 2020 Danaher Q1 Revenues Up 3 Percent; Joyce Retiring as CEO Apr 15, 2020 CMS Increases Payment Rates for High-Throughput SARS-CoV-2 Tests Load More Breaking News In Brief This Week: Illumina, Personalis, Proteomedix, and More Ancient DNA Details Population Dynamics Within Andean Tiwanaku Civilization Genomic Data Spanning 2K Years Gives Glimpse of Etruscan Origins, Population Changes People in the News: New Appointments at Hologic, Akoya Biosciences, Caris Life Sciences, More At NSGC, Genetic Counselors Address Race-Based Medicine, Ways to Change New Products Posted to GenomeWeb: Becton Dickinson, Cosmos-ID, OncoDNA, More The Scan US Booster Eligibility Decision The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions. Arizona Bill Before Judge The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction. Additional Genes Wales is rolling out new genetic testing service for cancer patients, according to BBC News. Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.